These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 9568770)

  • 1. Home flow rates in evaluation of lower urinary tract symptoms in men.
    Schwartz BF; Soderdahl DW; Thrasher JB
    Tech Urol; 1998 Mar; 4(1):15-7. PubMed ID: 9568770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the clinical value of a simple flowmeter in the management of male lower urinary tract symptoms.
    Chan CK; Yip SK; Wu IP; Li ML; Chan NH
    BJU Int; 2012 Jun; 109(11):1690-6. PubMed ID: 21933332
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Home and office uroflowmetry for evaluation of LUTS from benign prostatic enlargement.
    Porru D; Scarpa RM; Prezioso D; Bertaccini A; Rizzi CA;
    Prostate Cancer Prostatic Dis; 2005; 8(1):45-9. PubMed ID: 15655566
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of voiding position on uroflowmetric parameters and post-void residual urine volume in patients with benign prostatic hyperplasia.
    Unsal A; Cimentepe E
    Scand J Urol Nephrol; 2004; 38(3):240-2. PubMed ID: 15204379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Correlation between uroflowmetry, prostate volume, postvoid residue, and lower urinary tract symptoms as measured by the International Prostate Symptom Score.
    Ezz el Din K; Kiemeney LA; de Wildt MJ; Debruyne FM; de la Rosette JJ
    Urology; 1996 Sep; 48(3):393-7. PubMed ID: 8804492
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development and validation of a new treatment outcome score for men with LUTS.
    Weiss JP; Blaivas JG; Tash Anger JA; Di Blasio CJ; Panagopoulos G; Gerboc J
    Neurourol Urodyn; 2004; 23(2):88-93. PubMed ID: 14983416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significant relationship of time-dependent uroflowmetric parameters to lower urinary tract symptoms as measured by the International Prostate Symptom Score.
    Itoh H; Kojima M; Okihara K; Ukimura O; Ushijima S; Kawauchi A; Miki T
    Int J Urol; 2006 Aug; 13(8):1058-65. PubMed ID: 16903930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Urodynamic evaluation in diabetic patients with prostate enlargement and lower urinary tract symptoms.
    Dib PT; Trigo-Rocha F; Gomes CM; Srougi M
    Urol Int; 2008; 80(4):378-82. PubMed ID: 18587248
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk factors for lower urinary tract symptoms suggestive of benign prostatic hyperplasia in a community based population of healthy aging men: the Krimpen Study.
    Kok ET; Schouten BW; Bohnen AM; Groeneveld FP; Thomas S; Bosch JL
    J Urol; 2009 Feb; 181(2):710-6. PubMed ID: 19091352
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of a simple home flow test as a quality indicator for male patients treated for lower urinary tract symptoms suggestive of bladder outlet obstruction.
    Hansen MV; Zdanowski A
    Eur Urol; 1997; 32(1):34-8. PubMed ID: 9266229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical diagnosis of bladder outlet obstruction in men with lower urinary tract symptoms: reliability of commonly measured parameters and the role of idiopathic detrusor overactivity.
    Vesely S; Knutson T; Fall M; Damber JE; Dahlstrand C
    Neurourol Urodyn; 2003; 22(4):301-5. PubMed ID: 12808704
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Efficacy and safety of tamsulosin hydrochloride compared to doxazosin in the treatment of Indonesian patients with lower urinary tract symptoms due to benign prostatic hyperplasia.
    Rahardjo D; Soebadi DM; Sugandi S; Birowo P; Djati W; Wahyudi I
    Int J Urol; 2006 Nov; 13(11):1405-9. PubMed ID: 17083392
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between a new visual prostate symptom score (VPSS) and uroflowmetry parameters in men with lower urinary tract symptoms.
    Heyns CF; van der Walt CL; Groeneveld AE
    S Afr Med J; 2012 Mar; 102(4):237-40. PubMed ID: 22464506
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The pathophysiology of lower urinary tract symptoms after brachytherapy for prostate cancer.
    Blaivas JG; Weiss JP; Jones M
    BJU Int; 2006 Dec; 98(6):1233-7; discussion 1237. PubMed ID: 17125481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prostatic central zone volume, lower urinary tract symptom severity and peak urinary flow rates in community dwelling men.
    Corica FA; Jacobsen SJ; King BF; Bostwick DG; Jacobson DJ; Girman CJ; Lieber MM
    J Urol; 1999 Mar; 161(3):831-4. PubMed ID: 10022695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Urodynamics and lower urinary tract symptoms.
    Michielsen DP; Wyndaele JJ
    Acta Urol Belg; 1998 Oct; 66(3):7-9. PubMed ID: 9864870
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of residual fraction instead of residual volume in the evaluation of lower urinary tract symptoms.
    Memon A; Ather MH
    Tech Urol; 2000 Mar; 6(1):26-8. PubMed ID: 10708144
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does digital rectal examination affect uroflowmetry measurements?
    Aybek Z; Sinik Z; Oguzulgen I; Turan T; Güler G; Tuncay L
    Neurourol Urodyn; 2003; 22(2):138-41. PubMed ID: 12579631
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seasonal changes in symptom score and uroflowmetry in patients with lower urinary tract symptoms.
    Watanabe T; Maruyama S; Maruyama Y; Kageyama S; Shinbo H; Otsuka A; Ozono S
    Scand J Urol Nephrol; 2007; 41(6):521-6. PubMed ID: 17853015
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of symptomatic BPE among Malaysian men aged 50 and above attending screening during prostate health awareness campaign.
    Teh GC; Sahabudin RM; Lim TC; Chong WL; Woo S; Mohan M; Khairullah A; Abrams P
    Med J Malaysia; 2001 Jun; 56(2):186-95. PubMed ID: 11771079
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.